Status:
COMPLETED
Traditional Dietary Advice Vs. Mediterranean Diet in IBS
Lead Sponsor:
Sheffield Teaching Hospitals NHS Foundation Trust
Conditions:
Irritable Bowel Syndrome
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Irritable bowel syndrome (IBS) affects 5-10% of the population, and incurs substantial health impairment and healthcare utilization. Over 80% of individuals with IBS report food to trigger or aggravat...
Eligibility Criteria
Inclusion
- IBS Symptom Severity Scale(IBS-SSS) \> 75
- Online access
- English literate
Exclusion
- Organic gastrointestinal diseases (e.g. inflammatory bowel disease, GI cancer, coeliac disease, microscopic colitis, bile acid diarrhoea)
- Major abdominal surgery (except laparoscopy, appendectomy, cholecystectomy)
- History of eating disorder
- Body mass index \<20
- Current dietary interventions
- Current use of opioids/antibiotics
- Titrating dose of neuromodulators
- Severe systemic disease (e.g. cardiac, renal, respiratory, psychiatric) necessitating frequent medical consultations/hospitilisations
- Pregnant
- Diabetes mellitus
- Scleroderma
- Memory impairment
Key Trial Info
Start Date :
September 30 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 20 2024
Estimated Enrollment :
139 Patients enrolled
Trial Details
Trial ID
NCT05985018
Start Date
September 30 2023
End Date
December 20 2024
Last Update
March 14 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Royal Hallamshire Hospital
Sheffield, South Yorkshire, United Kingdom, S10 2JF